-+ 0.00%
-+ 0.00%
-+ 0.00%

TRAVERE THERAPEUTICS INC - OFFERS $475 MLN OF 0.50% CONVERTIBLE SENIOR NOTES DUE 2032 - SEC FILING

Reuters·05/07/2026 20:19:11

Please log in to view news